FDA Inspection 1286868 — Integrated Commercialization Solutions, Inc.
The FDA completed an inspection of Integrated Commercialization Solutions, Inc. on September 23, 2025 in Reno, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 23, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Reno, NV (United States)